What this Trial Is About

Researchers are evaluating a digital therapy intervention designed to help patients with chronic obstructive pulmonary disease (COPD) better manage their condition. This approach includes tools to assess inhalation technique, monitor inhalant medication use electronically, and guide patients with personalized feedback. The goal is to see if this digital program can reduce the frequency of severe COPD flare-ups, improve disease management, and decrease the overall burden of COPD by enhancing medication adherence. The intervention involves a complete digital therapy package that starts with testing inhalation capacity to provide tailored guidance on inhaler use. Patients receive electronic devices that track their inhalation medication usage, provide reminders for timely doses, and correct mistakes in inhalation technique. They can view their inhaler use records on their smartphones, while clinicians review monthly data to evaluate adherence. Participants will be involved in monitoring their inhalation behavior through digital devices and smartphone apps. Researchers will track the number of severe COPD exacerbations over 12 months as the primary outcome. The study includes ongoing assessments of medication use, adherence, and inhalation technique, supported by monthly clinician reviews. The total duration of participation is at least one year, focusing on improving patient self-management and reducing exacerbations.

Digital Therapy in Self-management of COPD Patients